These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9043561)
21. Cost-avoidance and qualitative analysis of clinical pharmacy interventions by psychiatric pharmacy residents at state psychiatric facilities. Gardner KN; Diefenderfer LA; Nelson LA; Iuppa C; Elliott E; Kleinhesselink K; Sass D; Sommi RW Am J Health Syst Pharm; 2016 Jan; 73(1):e46-53. PubMed ID: 26683680 [TBL] [Abstract][Full Text] [Related]
22. Transformation of a pharmacy department: impact on pharmacist interventions, error prevention, and cost. Crowson K; Collette D; Dang M; Rittase N Jt Comm J Qual Improv; 2002 Jun; 28(6):324-30. PubMed ID: 12066624 [TBL] [Abstract][Full Text] [Related]
23. Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical coordinator. Catania HF; Yee WP; Catania PN Am J Hosp Pharm; 1990 Dec; 47(12):2701-5. PubMed ID: 2278286 [TBL] [Abstract][Full Text] [Related]
24. Patient care contributions of clinical pharmacists in four ambulatory care clinics. Hatoum HT; Witte KW; Hutchinson RA Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost. Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928 [TBL] [Abstract][Full Text] [Related]
26. The integration of quality assessment and a patient-specific intervention/outcomes program. Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746 [TBL] [Abstract][Full Text] [Related]
27. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section. Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036 [TBL] [Abstract][Full Text] [Related]
28. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital. Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375 [TBL] [Abstract][Full Text] [Related]
29. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Bond CA; Raehl CL; Franke T Pharmacotherapy; 2001 Feb; 21(2):129-41. PubMed ID: 11213848 [TBL] [Abstract][Full Text] [Related]
31. Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital. Neville HL; Chevalier B; Daley C; Nodwell L; Harding C; Hiltz A; MacDonald T; Skedgel C; MacKinnon NJ; Slayter K Int J Pharm Pract; 2014 Jun; 22(3):216-22. PubMed ID: 23952872 [TBL] [Abstract][Full Text] [Related]
32. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. Miyagawa CI; Rivera JO Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508 [TBL] [Abstract][Full Text] [Related]
33. Focus and impact of pharmacists' interventions. Strong DK; Tsang GW Can J Hosp Pharm; 1993 Jun; 46(3):101-8. PubMed ID: 10126864 [TBL] [Abstract][Full Text] [Related]
34. Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis. Georgieva D; Markley B; DeClercq J; Choi L; Zuckerman AD J Manag Care Spec Pharm; 2024 Apr; 30(4):336-344. PubMed ID: 38555624 [TBL] [Abstract][Full Text] [Related]
35. Description and financial impact of ambulatory care pharmacy team interventions within an underserved patient population. Hasham S; Moye-Dickerson P; Thurston MM Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S42-S48. PubMed ID: 36371741 [TBL] [Abstract][Full Text] [Related]
36. Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit. Katona BG; Ayd PR; Walters JK; Caspi M; Finkelstein BW Am J Hosp Pharm; 1989 Jun; 46(6):1179-82. PubMed ID: 2750769 [TBL] [Abstract][Full Text] [Related]
37. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar. Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042 [TBL] [Abstract][Full Text] [Related]
38. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan. Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362 [TBL] [Abstract][Full Text] [Related]
39. Leveraging drug-utilization and external benchmarking data to drive change in prescribing behaviors. O'Neal BC; Couldry RJ; Wilkinson ST; Cannella CA; Williams CB; Scott LA; Simpson SQ Am J Health Syst Pharm; 2012 Nov; 69(21):1916-22. PubMed ID: 23111677 [TBL] [Abstract][Full Text] [Related]
40. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]